Expression of p53, bcl-2, bax, bcl-x2 and c-myc in radiation-induced apoptosis in Burkitt's lymphoma cells

Cell Death and Differentiation

Volumn 3, Issue 3, 1996, Pages 315-322

  Khanna, Kum Kum ^a   Wie, Tei ^a   Song, Qizhong ^a   Burrows, Scott R ^a   Moss, Denis J ^a   Krajewski, Stanislaw ^b   Reed, John C ^b   Lavin, Martin F ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; bax; bcl 2; bcl X(L); p53; Resistance; Susceptibility

Indexed keywords

MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL DEATH; CELL ONCOGENE; CONTROLLED STUDY; GAMMA RADIATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

HUMAN HERPESVIRUS 4;

EID: 0029834594     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bhatia K, Goldschmidts W, Gutterrez M, Gaidano G, Dalla-Favera R and Magrath I (1993) Hemi or Homozygosity: a requirement for some but not other p53 mutant protein to accumulate and exert a pathogenic event. FASEB J. 7: 951-956
2. Boise LH, Garcia MG, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB (1993) Bcl-2 related gene that function as a dominant regulator of apoptotic cell death. Cell 74: 597-608
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
4. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY and Sawczuk IS (1989) Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol. Cell. Biol. 9: 3473-3481
5. Chang M, Bramhall J, Graves S, Bonavida B and Wisniesk BJ (1989) Internucleosomal DNA cleavage preceeds diptheria toxin-induced cytolysis. J. Biol. Chem. 264: 15261-15267
6. Chen Y, Chen PL, Arnaiz N, Goodrich D and Lee WH (1991) Expression of wild type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Oncogene 6: 1799-1805
7. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH (1993) Thymocyte apoptosis induced by p53 dependent and independent pathways. Nature 362: 849-852
8. Delmolino L, Band H and Band V (1993). Expression and stability of p53 protein in normal human mammary epithelial cells. Carciongenesis 5: 827-832
9. Epperly MW, Santucci MA, Reed JC, Shields D, Halloran A and Greenberger JS (1994). Expression of the human Bcl-2 transgene increases the radiation resistance of a hematopoietic progenitor cell lines. Rad. Oncology Invest. 2: 77-83
10. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
11. Fanidi A, Harrington EA and Evan GI (1992). Cooperative interaction between c-myc and bcl-2. Nature 359: 554-556
12. Farrell PJ, Allan GJ, Shanahan ,F Vousden KH and Crook T (1991). p53 is frequently mutated in Burkitt's lymphoma cell lines. Embo J. 10: 2879-2887
13. Fernandez-Sarabia MJ and Bischoff JR (1993). Bcl-2 associates with the rasrelated protein R-ras p23. Nature 366: 274-275
14. Goldstone SD and Lavin MF (1991). Isolation of a cDNA clone encoding human galactoside binding protein overexpressed during glucocorticoid-induced cell death. Biochem. Biophys. Res. Comm. 178: 746-750
15. Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, Korsmeyer SJ and Greaves M (1994). Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J. Exp. Med. 179: 1789-1797
16. Henderson S, Rowe M, Gregory CD, Choom-Carter D, Wang F, Keiff E and Rickinson AB (1991). Induction of a bcl-2 Expression by Epstein-Barr Virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1115
17. Hockenbery DM, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
18. Hoshikawa Y, Izawa M and Ichii S (1988) Cloning of glucocorticoid-responsive mRNA in the rat thymus. Endocrinol Japon 35: 429-437
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311
20. Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rickinson AB and Moss DJ (1993) EBV pepetide epitope sensitization restores human cytotoxic T-cell recognition of Burkitt's lymphoma cells-evidence for a critical role for ICAM-2. J. Immunol. 150: 5154-5162
21. Kozopas KM, Yang T, Buchan HL, Zhou P and Craig RW (1993) MCL-1 a gene expressed in programmed myeloid cell differentiation has sequence similarity to BCL-2. Proc. Natl. Acad. Sci. USA 90: 3516-3520
22. Krajewski S, Blornquist C, Franssila K, Krajewski M, Wasenius V-M and Niskanen E (1995). Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma (in press)
23. Krajewski S, Krajewski M, Shabaik A, Wang H,-G Irie S, Fong L and Reed JC (1994). Immunohistochemical analysis of invivo patterns of Bcl-X expression. Cancer Res. 54: 5501-5507
24. Lane DP (1992) P53 Guardian of the genome. Nature 358: 15-16
25. Lenoir GM, Vuillaume M and Bonardel C (1985) The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's Lymphoma. IARC Sci publ 60: 309-318
26. Lin EY, Orlofsky A, Berger MS and Prystowsky MB (1993) Characterization of A1 a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979-1988
27. Lotem J and Sachs L (1993a) Regulation by bcl-2 c-myc and p53 susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemic cell. Cell Growth Differ. 4: 41-47
28. Lotem J and Sachs L (1993b) Hemotapoietic cells from mice deficient in wildtype p53 are more resistant to induction of apoptosis by some agents. Blood 82: 1092-1096
29. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993a) p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362: 847-849
30. Lowe SW, Ruley HE, Jacks T and Housman DE (1993b) P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
31. Marcu KB, Bossone SA and Patel AJ (1992) Myc function and regulation. Ann. Rev. Biochem. 61: 809-860
32. ++ mediated endonuclease activation. Science 242: 256-259
33. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP and Korsmeyer SJ (1989) Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell. Biol. 10: 1901-1907
34. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215
35. Moss DJ, Burrows SR, Baxter GD and Lavin MF (1991) T cell-T cell killing is induced by specific epitopes: Evidence for an apoptotic mechanism. J. Exp. Med. 173: 681-686
36. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW (1993) Role of the p53 tumour suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53: 4776-4780
37. Oltvai ZN, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death. Cell 74: 609-619
38. Owens GP, Hahn W and Cohen JJ (1991) Identification of mRNA's associated with programmed cell death in immature thymocytes. Mol. Cell. Biol. 11: 4177-4188
39. Pezzella F, Tse A, Cordell J,L Pulford KAF, Gatter KC and Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14'8 chromosomal translocation. Am. J. Pathol. 137: 225-232
40. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korysmeyer S and White E (1992) The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19-KDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89: 7742-7746
41. Rooney CM, Rickinson AB, Moss DJ, Lenoir GM and Epstein MA (1984) Paired Epstein-Barr virus carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma pateints: Comparative sensitivity to non-specific and to allospecific cytotoxic T cell responses in vitro. Int. J. Cancer 34: 339-348
42. Sarraf CE and Bowen ID (1986) Kinetic studies on a murine sacoma and an analysis of apoptosis. Br. J. Cancer 54: 989-998
43. +T and natural killer cells without detectable p53 protein. J. Immunol. 24: 2914-2917
44. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B and Liebermann D (1994) Immediate early upregulation of bax expression by p53 but not TGF beta 1:a paradagin for distinct apoptotic pathways. Oncogene 9: 1791-1798
45. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in Thymocytes. Cell 67: 879-888
46. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP and Green DR (1992) Role for C-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257: 212-214
47. Shung B, Miyakoshi J and Takeba H (1994). X-ray-induced transcriptional activation of c-myc and XRCC1 gene in ataxia-telangiectasia cells. Mutat. Res. 307: 43-51
48. Skarlka M, Matyasova J and Ceskova M (1976) DNA in chromatin or irradiated Lymphoid tissues degrades in vivo into regular fragments. FEBS Lett. 72: 271-274
49. Smith CA, Williams GT, Kingston R, Jenkinson R and Owen EJ (1989) Antibodies CD3/Tcell receptor complex induce death by apoptosis in immature T cells in thymic culture. Nature 337: 181-189
50. Song Q ,Baxter GD, Kovacs EM, Findik D and Lavin MF (1992) Inhibition of apoptosis in human tumour cells by okadaic acid. J. Cell. Physiol. 153: 550-556
51. Strasser A, Harris AW and Cory S (1991) Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899
52. Strasser A, Harris AW, Jacks T and Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53 independant mechanism inhibitable by Bcl-2. Cell 79: 329-339
53. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA and Reed JC (1995). Cloning and fuctional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 80: 279-284
54. Teh BS, Chen P, Lavin MF, Seow WK and Thong YH (1991) Demonstration of the induction of apoptosis (programmed cell death) by tetrandine a novel anti-inflammatory agent. Int. Immunopharmac. 13: 1117-1126
55. Vaux DL, Cory S and Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperate with c-myc to immortalize pre-B cells. Nature 335: 440-442
56. Vogelstein B and Kinzle rKW (1992) p53 function and dysfunction. Cell 70: 523-526
57. Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey III L, Troppmair J, Rapp UR and Reed JC (1994) Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9: 2751-2756
58. Wilson RE, Taylor SL, Atherton GT, Johnston D, Waters CM and Norton JD (1993) Early response gene signalling cascades activated by ionizing radiation in primary human B cells. Oncogene 8: 3229-3237
59. Wiman KG, Magnusson KP, Ramquist J and Klein G (1991) Mutant p53 detected in a majority of Burkitt's lymphoma cell lines by monclonal PAb240. Oncogene 6: 1633-1639
60. Wyllie AH, Morris RG, Smith AL and Dunlop D (1984) Chromatin in apoptosis: association with condensed morphology and dependence on macromolecular synthesis. J. Pathol. 142: 67-77
61. L and Bcl-2 displaces Bax and promotes cell death. Cell 80: 285-291
62. Yin YX, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM (1992) Wild type p53 restores cell cycle control and inhibits gene amplificaton in cells with mutant p53 allete. Cell 70: 937-948
63. Yuh YS and Thompson EB (1989) Glucocorticoid effect of oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. J. Biol. Chem. 264: 10904-10910